Today’s stock pick update – Open Now

Learn More Followers Made 905% on Tesla, Now A New Stock Is Even Better Stop wasting time looking for the right stocks. TSLA Up 905% since we gave it’s first buy signal, others have done just as well or better.(Ad) Get the next stock trade that could move 300-1,500% or more. Moderna’s COVID Vaccine Overwhelmingly Passes Key Committee Vote – FDA Approval Expected As Early As Friday

The FDA’s Vaccines and Related Biological Products Advisory Committee overwhelmingly backed Moderna’s coronavirus vaccine for emergency use late Thursday, paving the way for the agency to approve the shot as early as today. The nonbonding decision passed 20-0 with one abstention by the committee exactly one week after the group voted to recommend Pfizer Read More

Aqua Metals Inc (NASDAQ: AQMS): Aqua Metals shares are up 20% today following news that it has retired its $9 million debt obligation with Veritex Bank, leaving the company essentially debt free. “The retirement of our loan with Veritex Bank is yet another positive step for Aqua Metals as we have accelerated our transition to a capital light business model. With this action, our ... Read More

GFF is an interesting small-cap stock to keep on a watchlist I believe that part of this, not surprisingly has to do with the enthusiasm and hope that has come from positive news on the vaccine front, as Pfizer was granted emergency use authorization for its vaccine last week, and now Moderna is on deck, with its vaccine expected to receive FDA clearance before the end of business on Friday. Read More

Featured Stock Forte Biosciences, Inc. (FBRX) – Buy Price: $40.00 or better Forte Biosciences Inc. operates as a clinical-stage dermatology company in the United States. It is developing a live biotherapeutic FB-401 that has completed Phase 1/2a clinical trial to treat inflammatory skin diseases for pediatric atopic dermatitis patients. The company is based in Torrance, California. Read More

Other Top Stories Volkswagen faces "massive" shortage of electronic parts 5 live menswear shows planned for hybrid Milan Fashion Week Google's antitrust case won't go to trial until Sept. 2023 Records show Foxconn, Wisconsin nearing agreement FAA seeks fines against passengers for rows over face masks

Trend Following Picks Forte Biosciences, Inc. (FBRX) – Buy Price: $40.00 or better Sierra Metals Inc. (SMTS) – Buy Price: $3.50 or better Yandex N.V. (YNDX) – Buy Price: $71.00 or better Advanced Drainage Systems, Inc. (WMS) – Buy Price: $76.00 or better Hudson Technologies, Inc. (HDSN) – Buy Price: $1.60 or better All Picks

Reversal Picks AIM ImmunoTech Inc. (AIM) Buy Target $2.07 Sell Target $2.32 500.com Limited (WBAI) Buy Target $3.04 Sell Target $3.34 Harmony Gold Mining Company Limited (HMY) Buy Target $4.74 Sell Target $5.19 UP Fintech Holding Limited (TIGR) Buy Target $5.99 Sell Target $6.54 GoldMining Inc. (GLDG) Buy Target $2.48 Sell Target $2.81 All Picks

Low Price Stock Picks Camber Energy, Inc. (CEI) Galiano Gold Inc. (GAU) Avino Silver & Gold Mines Ltd. (ASM) IT Tech Packaging, Inc. (ITP) Genesis Healthcare, Inc. (GEN) All Picks

Already subscribed to our premium service? Click here to Login. Not a TradersPro subscriber yet? Learn More About TradersPro Here - Learn The # 1 Key To Successful Stock Investing Profits

 

This email was sent to Phanhoa1821960.b3d3b461@blogger.com  from TradersPro by Investiv, LLC 265 N. Main | Ste. D #283 Kaysville | UT | 84037  Unsubscribe or Mange which emails you get from TradersPro Disclaimers, Terms & Conditions | Privacy Policy Copyright 2020  Investing is Inherently Risky - There are risks inherent in all investments, which may make such investments unsuitable for certain persons. These include, for example, economic, political, currency exchange, rate fluctuations, and limited availability of information on international securities. You may lose all of your money trading and investing. Do NOT enter any trade without fully understanding the worst-case scenarios of that trade. And do NOT trade with money you cannot afford to lose. Past performance of an investment is not necessarily indicative of its future results. No assurance can be given that any implied recommendation will be profitable or will not be subject to losses.